HA (n = 19) | Control (n = 18) | OR (95 % CI) | P value | |
---|---|---|---|---|
Preoperative characteristics | ||||
Age, years | 64 (30–81) | 69 (51–81) | 0.1737 | |
Male | 12 | 14 | 0.50 (0.09, 2.56) | 0.4756 |
Female | 7 | 4 | ||
BMI, kg/m2 | 27 (18–35) | 27 (20–39) | 0.6593 | |
EuroSCORE | 4.0 ± 3.6 | 6.0 ± 4.6 | 0.154 | |
Resistance | 411.7 ± 210.2 | 442.7 ± 101.6 | 0.6948 | |
Phase angle | 5.1 ± 1.5 | 4.9 ± 0.7 | 0.7078 | |
TBW | 56.3 ± 14.1 | 46.6 ± 11.3 | 0.1205 | |
MCI | 0 | 0 | 1 | |
Asthma | 0 | 0 | 1 | |
COPD | 3 | 3 | 0.94 (0.11–8.15) | 1 |
NIDDM | 6 | 4 | 1.60 (0.30–9.56) | 0.714 |
IDDM | 0 | 2 | 0 (0, 4.99) | 0.2297 |
CKD | 0 | 0 | 1 | |
Cardiac decompensation | 2 | 1 | 1.96 (0.09–124.72) | 1 |
PAOD | 3 | 1 | 3.10 (0.22–176.81) | 0.6039 |
Art. hypertension | 10 | 10 | 0.89 (0.20–3.90) | 1 |
Dialysis | 0 | 0 | 1 | |
Angina pectoris (absence of) | 16 | 13 | 0.5392 | |
Angina pectoris (stable) | 3 | 4 | ||
Angina pectoris (instable) | 0 | 1 | ||
LVEF >50 % | 12 | 13 | 0.4756 | |
LVEF 30–50 % | 7 | 4 | ||
LVEF <30 % | 0 | 1 | ||
Intraoperative characteristics | ||||
Valve procedure, M/F | 7/4 | 7/4 | 0.4819 | |
CABG, M/F | 2/1 | 5/0 | ||
Combined procedure, M/F | 3/2 | 2/0 | ||
Anesthesia time, min | 474 (290–673) | 427 (277–570) | 0.1683 | |
Surgery time, min | 369 (219–630) | 327 (225–493) | 0.2152 | |
CPB time, min | 191 (112–288) | 170 (83–274) | 0.2064 | |
AoCC time, min | 138 (57–242) | 117 (36–179) | 0.1423 | |
Fibrinogen, g | 1.7 (0–5) | 0.8 (0–4) | 0.077 | |
Thrombocytes, units | 0.15 (0–1) | 0.2 (0–1) | 0.6304 | |
PCC, IE | 605 (0–2000) | 389 (0–3000) | 0.415 | |
FFP, units | 0.5 (0–9) | 0 | 0.3306 | |
Erythrocytes, units | 1.4 (0–7) | 0.7 (0–3) | 0.2021 | |
Cristalloids, ml | 5239 ± 1569 | 4311 ± 1230 | 0.0526 | |
Colloids, ml | 571 ± 327 | 514 ± 130 | 0.4873 | |
Diuresis | 826 ± 352 | 978 ± 589 | 0.3516 | |
Postoperative characteristics | ||||
LOS-ICU, days | 2.3 ± 2.0 | 2.4 ± 1.9 | 0.8721 | |
Mechanical ventilation, days | 0.7 ± 1.6 | 0.2 ± 0.4 | 0.19 | |
Balance 1POD | 9374 ± 4785 | 7303 ± 2664 | 0.1124 | |
vaECMO, n | 2 | 0 | 0.4865 | |
30-day mortality | 1 | 0 | 1 |